Updated:
Iter Investments
Iter Investments is a venture capital firm focused on supporting emerging companies developing alternative therapeutics for behavioral and mental health.
Iter Investments
Iter Investments is a venture capital firm focused on supporting emerging companies developing alternative therapeutics for behavioral and mental health. The firm invests in and supports breakthrough companies in the alternative therapeutics industry to revolutionize mental and behavioral health. Its team includes builders, investors, lawyers, scientists, physicians, clinicians, and technologists fueling entrepreneurs impacting global mental health and well-being.
General information
Firm type
Private Equity
Year founded
2020
Location
Region
North America
Country
United States
City
Fort Lauderdale
Corporate office
Fort Lauderdale, FL, United States
Principals
Dustin Robinson
Esq. CPA, Founder
Robert Velarde
Founder
Dr. Michelle Weiner
DO MPH, Clinical Lead
Dr. Scott Fisher
MD, Psychiatric Lead
Edgar Asebey
Esq, FDA Lead
John M.H. Gregg
MBA, CLP, Commercialization Lead
David Wood
Esq. PhD, Intellectual Property Lead
Rayyan Zafar
Research Lead
Andrew Hall
PHD, Scientific Lead
Matt Savarick
Tech Lead
Amanda Barton
Legal Advisor
Samuel Baum
Marketing Lead
Sector focus
Frequently asked questions
What is Iter Investments' specific investment focus?
Iter Investments is a venture capital firm exclusively focused on the psychedelic medicine and mental health sector. The firm invests in early-stage companies across the value chain, including drug discovery platforms, clinical research organizations, and the clinic networks that administer psychedelic-assisted therapies.
Which portfolio companies have been publicly linked to Iter Investments?
Publicly disclosed portfolio positions include atai Life Sciences, a clinical-stage biopharmaceutical platform developing multiple psychedelic compounds. The firm also targets specialized treatment-clinic operators and drug-discovery ventures, though the full portfolio is not publicly detailed.
What jurisdictions does Iter Investments focus on?
Iter Investments deploys capital primarily in North America and Europe. These regions have the most advanced regulatory frameworks for psychedelic-assisted therapies, which reduces binary legal risk for the clinic networks and drug developers the firm backs.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: